A detailed history of First Citizens Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First Citizens Financial Corp holds 5,777 shares of ABBV stock, worth $984,111. This represents 0.6% of its overall portfolio holdings.

Number of Shares
5,777
Previous 5,724 0.93%
Holding current value
$984,111
Previous $981,000 16.21%
% of portfolio
0.6%
Previous 0.58%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$163.84 - $199.33 $8,683 - $10,564
53 Added 0.93%
5,777 $1.14 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $17,800 - $20,787
-115 Reduced 1.97%
5,724 $981,000
Q1 2024

May 31, 2024

BUY
$159.82 - $182.1 $3,835 - $4,370
24 Added 0.41%
5,839 $1.06 Million
Q2 2023

Jul 07, 2023

BUY
$132.51 - $164.9 $173,588 - $216,019
1,310 Added 29.08%
5,815 $783,000
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $13,831 - $16,587
100 Added 2.27%
4,505 $728,000
Q3 2022

Oct 12, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 2.22%
4,405 $591,000
Q2 2022

Jul 08, 2022

BUY
$137.62 - $174.96 $43,350 - $55,112
315 Added 7.52%
4,505 $690,000
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $532 - $603
-5 Reduced 0.12%
4,190 $452,000
Q2 2021

Jul 09, 2021

SELL
$105.21 - $117.21 $23,567 - $26,255
-224 Reduced 5.07%
4,195 $473,000
Q1 2021

Apr 09, 2021

SELL
$102.3 - $112.62 $31,815 - $35,024
-311 Reduced 6.58%
4,419 $478,000
Q4 2020

Feb 01, 2021

SELL
$80.49 - $108.67 $18,512 - $24,994
-230 Reduced 4.64%
4,730 $507,000
Q3 2020

Oct 16, 2020

SELL
$85.91 - $100.83 $2,233 - $2,621
-26 Reduced 0.52%
4,960 $434,000
Q2 2020

Jul 30, 2020

SELL
$73.37 - $98.18 $3,961 - $5,301
-54 Reduced 1.07%
4,986 $490,000
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $5,805 - $8,801
90 Added 1.82%
5,040 $384,000
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $357,043 - $446,737
4,950 New
4,950 $438,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Citizens Financial Corp Portfolio

Follow First Citizens Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Financial Corp with notifications on news.